Vitamin D is increasingly recognized for roles beyond bone health, with growing evidence linking low levels to various ocular problems. This article summarizes current understanding of how vitamin D deficiency and insufficiency may influence eye structures, visual function, and age-related degeneration, emphasizing findings from observational studies and proposed biological mechanisms.

Vitamin D receptors are present in the cornea, lens, retina, and ciliary body, suggesting physiological relevance in ocular tissues. Deficiency—commonly defined as serum 25-hydroxyvitamin D below 20 ng/mL—has been associated with increased ocular inflammation, altered tear film stability, and a greater prevalence of conditions such as dry eye syndrome and uveitis. Vitamin D’s immunomodulatory effects include down-regulation of pro-inflammatory cytokines (for example, IL-6 and TNF-alpha) and support for antioxidant pathways, which may protect the corneal and retinal epithelium from chronic inflammatory damage.

At the retinal level, vitamin D may influence mitochondrial function and vascular homeostasis. Observational studies report lower vitamin D status in people with diabetic retinopathy and other retinal microvascular abnormalities, and some cross-sectional data link lower serum levels to an increased risk of advanced age-related macular degeneration (AMD). These associations do not establish causation, but they align with plausible mechanisms: vitamin D’s potential to reduce oxidative stress, limit pathological angiogenesis, and maintain the integrity of the retinal blood barrier.

Muscle and nerve function relevant to vision also appear to be affected by vitamin D. Adequate vitamin D supports calcium metabolism and neuromuscular performance; insufficiency may contribute to extra-ocular muscle fatigue, blurred vision with prolonged near tasks, and convergence difficulties. In pediatric populations, preliminary studies have suggested correlations between lower vitamin D levels and myopia progression, though randomized trials are needed to clarify these relationships.

Age-related eye degeneration—cataracts, glaucoma, and AMD—shares common pathways of chronic inflammation, oxidative injury, and dysregulated calcium homeostasis. Observational evidence indicates that higher vitamin D status correlates with reduced odds of advanced AMD and possibly slower lens opacification, whereas animal and mechanistic studies suggest vitamin D may help protect retinal ganglion cells and influence intraocular pressure regulation.

For clinicians and patients, it is useful to consider vitamin D status as one element of a multifactorial approach to ocular health. Nutrient synergy is important: cofactors like magnesium, vitamin K, and omega-3 fatty acids support vitamin D metabolism and vascular function in the eye. Practical resources discussing broader nutrient strategies for older adults can be found in reviews of appropriate supplements for older adults, while summaries of related micronutrient roles are available in accessible overviews such as this vitamin B12 benefits guide and an external telegraph summary of vitamin B12 research.

Comprehensive reviews on ocular vitamin D relationships help contextualize individual studies; one such discussion relevant to clinicians and curious readers is available at how vitamin D deficiency affects the eyes. Overall, while definitive interventional trials are limited, maintaining sufficient vitamin D as part of balanced nutrition and routine eye care is consistent with current evidence-based strategies for supporting long-term ocular health.